US Stock MarketDetailed Quotes

TG Therapeutics (TGTX)

Watchlist
  • 30.710
  • +1.170+3.96%
Close Jan 15 16:00 ET
  • 30.900
  • +0.190+0.62%
Post 19:48 ET
4.88BMarket Cap11.09P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

TG Therapeutics (TGTX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
92.79%161.71M
92.13%141.15M
90.40%120.86M
40.80%329M
146.04%108.19M
-49.41%83.88M
357.05%73.47M
713.46%63.47M
8,290.02%233.66M
54,863.75%43.97M
Operating revenue
92.79%161.71M
92.13%141.15M
89.91%119.69M
40.80%329M
146.04%108.19M
-49.41%83.88M
357.05%73.47M
707.71%63.03M
8,290.02%233.66M
54,863.75%43.97M
Cost of revenue
200.75%28.09M
128.06%18.94M
185.63%15.54M
172.35%38.49M
96.07%15.4M
166.20%9.34M
334.54%8.3M
534.89%5.44M
5,232.45%14.13M
261,700.00%7.85M
Gross profit
79.26%133.62M
87.55%122.21M
81.47%105.32M
32.34%290.52M
156.90%92.79M
-54.08%74.54M
360.09%65.16M
735.49%58.03M
8,611.55%219.53M
46,805.19%36.12M
Operating expense
67.87%104.25M
55.05%87.37M
43.67%96.69M
24.98%248.59M
29.29%62.84M
30.68%62.1M
-4.23%56.35M
53.18%67.3M
-9.93%198.9M
-37.38%48.6M
Selling and administrative expenses
51.01%63.37M
43.30%55.59M
45.55%50.33M
25.75%154.3M
25.07%38.96M
28.07%41.97M
26.29%38.79M
23.20%34.58M
28.51%122.71M
-35.07%31.15M
-General and administrative expense
51.01%63.37M
43.30%55.59M
45.55%50.33M
25.75%154.3M
25.07%38.96M
28.07%41.97M
26.29%38.79M
23.20%34.58M
28.51%122.71M
-35.07%31.15M
Research and development costs
102.99%40.88M
81.03%31.78M
41.68%46.36M
23.75%94.29M
36.82%23.87M
36.50%20.14M
-37.57%17.56M
106.19%32.72M
-39.22%76.19M
-41.12%17.45M
Operating profit
136.17%29.37M
295.22%34.84M
193.01%8.62M
103.21%41.93M
339.88%29.95M
-89.17%12.43M
119.73%8.82M
74.94%-9.27M
109.45%20.63M
83.90%-12.49M
Net non-operating interest income expense
37.95%-6.72M
-68.87%-6.72M
-195.32%-6.76M
-90.47%-24.03M
-190.46%-7.06M
-191.73%-10.83M
-9.65%-3.98M
19.55%-2.29M
-23.79%-12.62M
15.06%-2.43M
Non-operating interest expense
-37.95%6.72M
68.87%6.72M
195.32%6.76M
90.47%24.03M
190.46%7.06M
191.73%10.83M
9.65%3.98M
-19.55%2.29M
23.79%12.62M
-15.06%2.43M
Other net income (expense)
22.47%3.27M
63.14%2.79M
309.43%3.6M
52.52%7.69M
188.20%2.57M
-6.75%2.67M
147.76%1.71M
45.70%880K
7.43%5.04M
-53.89%890K
Other non- operating income (expenses)
22.47%3.27M
63.14%2.79M
309.43%3.6M
52.52%7.69M
188.20%2.57M
-6.75%2.67M
147.76%1.71M
45.70%880K
7.43%5.04M
-53.89%890K
Income before tax
507.05%25.91M
371.99%30.92M
151.21%5.47M
95.94%25.59M
281.47%25.45M
-96.25%4.27M
113.76%6.55M
72.78%-10.68M
105.84%13.06M
82.13%-14.03M
Income tax
-94,168.56%-364.99M
933.23%2.73M
1,306.90%408K
466.92%2.21M
444.10%2.12M
388K
-328K
29K
390K
390K
Net income
9,974.61%390.9M
309.75%28.19M
147.26%5.06M
84.52%23.38M
261.84%23.33M
-96.59%3.88M
114.45%6.88M
72.71%-10.71M
105.66%12.67M
81.63%-14.42M
Net income continuous Operations
9,974.61%390.9M
309.75%28.19M
147.26%5.06M
84.52%23.38M
261.84%23.33M
-96.59%3.88M
114.45%6.88M
72.71%-10.71M
105.66%12.67M
81.63%-14.42M
Minority interest income
Net income attributable to the parent company
9,974.61%390.9M
309.75%28.19M
147.26%5.06M
84.52%23.38M
261.84%23.33M
-96.59%3.88M
114.45%6.88M
72.71%-10.71M
105.66%12.67M
81.63%-14.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
9,974.61%390.9M
309.75%28.19M
147.26%5.06M
84.52%23.38M
261.84%23.33M
-96.59%3.88M
114.45%6.88M
72.71%-10.71M
105.66%12.67M
81.63%-14.42M
Basic earnings per share
8,866.67%2.69
280.00%0.19
142.86%0.03
77.78%0.16
260.00%0.16
-96.25%0.03
114.71%0.05
75.00%-0.07
105.45%0.09
74.36%-0.1
Diluted earnings per share
12,050.00%2.43
325.00%0.17
142.86%0.03
66.67%0.15
250.00%0.15
-97.26%0.02
111.76%0.04
75.00%-0.07
105.45%0.09
74.36%-0.1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 92.79%161.71M92.13%141.15M90.40%120.86M40.80%329M146.04%108.19M-49.41%83.88M357.05%73.47M713.46%63.47M8,290.02%233.66M54,863.75%43.97M
Operating revenue 92.79%161.71M92.13%141.15M89.91%119.69M40.80%329M146.04%108.19M-49.41%83.88M357.05%73.47M707.71%63.03M8,290.02%233.66M54,863.75%43.97M
Cost of revenue 200.75%28.09M128.06%18.94M185.63%15.54M172.35%38.49M96.07%15.4M166.20%9.34M334.54%8.3M534.89%5.44M5,232.45%14.13M261,700.00%7.85M
Gross profit 79.26%133.62M87.55%122.21M81.47%105.32M32.34%290.52M156.90%92.79M-54.08%74.54M360.09%65.16M735.49%58.03M8,611.55%219.53M46,805.19%36.12M
Operating expense 67.87%104.25M55.05%87.37M43.67%96.69M24.98%248.59M29.29%62.84M30.68%62.1M-4.23%56.35M53.18%67.3M-9.93%198.9M-37.38%48.6M
Selling and administrative expenses 51.01%63.37M43.30%55.59M45.55%50.33M25.75%154.3M25.07%38.96M28.07%41.97M26.29%38.79M23.20%34.58M28.51%122.71M-35.07%31.15M
-General and administrative expense 51.01%63.37M43.30%55.59M45.55%50.33M25.75%154.3M25.07%38.96M28.07%41.97M26.29%38.79M23.20%34.58M28.51%122.71M-35.07%31.15M
Research and development costs 102.99%40.88M81.03%31.78M41.68%46.36M23.75%94.29M36.82%23.87M36.50%20.14M-37.57%17.56M106.19%32.72M-39.22%76.19M-41.12%17.45M
Operating profit 136.17%29.37M295.22%34.84M193.01%8.62M103.21%41.93M339.88%29.95M-89.17%12.43M119.73%8.82M74.94%-9.27M109.45%20.63M83.90%-12.49M
Net non-operating interest income expense 37.95%-6.72M-68.87%-6.72M-195.32%-6.76M-90.47%-24.03M-190.46%-7.06M-191.73%-10.83M-9.65%-3.98M19.55%-2.29M-23.79%-12.62M15.06%-2.43M
Non-operating interest expense -37.95%6.72M68.87%6.72M195.32%6.76M90.47%24.03M190.46%7.06M191.73%10.83M9.65%3.98M-19.55%2.29M23.79%12.62M-15.06%2.43M
Other net income (expense) 22.47%3.27M63.14%2.79M309.43%3.6M52.52%7.69M188.20%2.57M-6.75%2.67M147.76%1.71M45.70%880K7.43%5.04M-53.89%890K
Other non- operating income (expenses) 22.47%3.27M63.14%2.79M309.43%3.6M52.52%7.69M188.20%2.57M-6.75%2.67M147.76%1.71M45.70%880K7.43%5.04M-53.89%890K
Income before tax 507.05%25.91M371.99%30.92M151.21%5.47M95.94%25.59M281.47%25.45M-96.25%4.27M113.76%6.55M72.78%-10.68M105.84%13.06M82.13%-14.03M
Income tax -94,168.56%-364.99M933.23%2.73M1,306.90%408K466.92%2.21M444.10%2.12M388K-328K29K390K390K
Net income 9,974.61%390.9M309.75%28.19M147.26%5.06M84.52%23.38M261.84%23.33M-96.59%3.88M114.45%6.88M72.71%-10.71M105.66%12.67M81.63%-14.42M
Net income continuous Operations 9,974.61%390.9M309.75%28.19M147.26%5.06M84.52%23.38M261.84%23.33M-96.59%3.88M114.45%6.88M72.71%-10.71M105.66%12.67M81.63%-14.42M
Minority interest income
Net income attributable to the parent company 9,974.61%390.9M309.75%28.19M147.26%5.06M84.52%23.38M261.84%23.33M-96.59%3.88M114.45%6.88M72.71%-10.71M105.66%12.67M81.63%-14.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 9,974.61%390.9M309.75%28.19M147.26%5.06M84.52%23.38M261.84%23.33M-96.59%3.88M114.45%6.88M72.71%-10.71M105.66%12.67M81.63%-14.42M
Basic earnings per share 8,866.67%2.69280.00%0.19142.86%0.0377.78%0.16260.00%0.16-96.25%0.03114.71%0.0575.00%-0.07105.45%0.0974.36%-0.1
Diluted earnings per share 12,050.00%2.43325.00%0.17142.86%0.0366.67%0.15250.00%0.15-97.26%0.02111.76%0.0475.00%-0.07105.45%0.0974.36%-0.1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -